Features
<b><i>Online Extra:</b></i> Pao Lawyers Slap Facebook With Discrimination Suit
A former Facebook employee is suing the company for gender discrimination and harassment, claiming her supervisor belittled her at work and asked why she 'did not just stay home and take care of her child.'
<b><i>Online Extra:</b></i> Fired Employees Claim Work iPad Stored Personal Texts
A suit by two former New Jersey-based employees of Anheuser-Busch ' claiming they were wrongfully discharged based on messages from their personal devices that were transferred to a company tablet ' is headed for federal court.
Features
<b><i>Online Extra:</b></i> Hulu Lawyers Land Punch in Privacy Suit
U.S. Magistrate Judge Laurel Beeler said she didn't want February's hearing in a privacy suit against Hulu LLC to feel like 'a wake.' But the Northern District of California judge put the case on life support, at the very least, indicating that she's leaning toward knocking out the remaining claims in a 2011 suit under the Video Privacy Protection Act.
Features
<b><i>Online Extra:</b></i> Judge Orders Litigious Adult Website to Pay $5.6 Million
A federal judge has ordered a litigious adult website to pay $5.6 million in attorney fees and costs under the Copyright Act, saying its motives for suing Giganews Inc. and Livewire Services Inc. had more to do with creating a tax write-off for its owner than with protecting its copyrights.
Features
<b><i>Online Extra:</b></i> Firms Claim Bragging Rights in New Field of Patent Litigation
If there really is a'death squad for patents, it may not be found at the Patent Trial and Appeal Board. A more likely location is the Plano, TX, office of David O'Dell, chairman of Haynes and Boone's patent trials practice group.
Movers & Shakers
A Collection of Moves in the Cybersecurity and Privacy Practice Areas
<b><i>Online Extra:</b></i> Premera Data Breach Compromises Up to 11 Million Users' Records
Over the last year, cyberbreaches targeting health care and insurance companies have made headlines almost as frequently as those of large well-established business. Due to the sensitive material collected by companies in the health care space, companies in this industry are a particularly attractive target to cybercriminals and painful for organizations and their customers.
Features
<b><i>Online Extra:</b></i> New Russian Data Residency Law Will Soon Take Effect
There is a new Russian data residency law that will likely impact many companies, which somehow have business connections with Russia.
<b><i>Online Extra:</b></i> Twitch Alerts Users of Potential Data Breach
Retail giants, banks and insurance firms may be the companies most likely to make headlines following a cyberbreach, but that doesn't mean that smaller organizations and services are without risk, nor does it mean that the data these businesses collect are any less sensitive when compromised.
<b><i>Online Extra:</b></i> Law Firms to Form Cybersecurity Alliance
As pressure to strengthen defenses against security breaches increases, at least five Am Law 100 and Magic Circle firms are working to form an alliance that would allow them to ultimately share information with each other about cyber threats and vulnerability.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- Surveys in Patent Infringement Litigation: The Next FrontierMost experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.Read More ›
- The DOJ's New Parameters for Evaluating Corporate Compliance ProgramsThe parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.Read More ›
- In the SpotlightOn May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug & Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.Read More ›
